Healthcare -
Biotechnology - NASDAQ - US
$ 6.17
6.56 %
$ 192 M
Market Cap
-2.32
P/E
ACRV - STOCK-BASED COMPENSATION
Stock-based Compensation ACRV - Acrivon Therapeutics, Inc. Common Stock
11.6 M
LAST VALUE
383.49%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR